抗生素耐药性
医学
鲍曼不动杆菌
重症监护医学
抗生素
癌症
屎肠球菌
铜绿假单胞菌
肺炎克雷伯菌
金黄色葡萄球菌
不动杆菌
内科学
微生物学
细菌
生物
大肠杆菌
基因
生物化学
遗传学
作者
Amila K. Nanayakkara,Helen W. Boucher,Vance G. Fowler,Amanda Jezek,Kevin Outterson,David E. Greenberg
摘要
Infection is the second leading cause of death in patients with cancer. Loss of efficacy in antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing success of cancer therapy. In this review, the authors focus on recent updates on the impact of antibiotic resistance in the cancer setting, particularly on the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). This review highlights the health and financial impact of antibiotic resistance in patients with cancer. Furthermore, the authors recommend measures to control the emergence of antibiotic resistance, highlighting the risk factors associated with cancer care. A lack of data in the etiology of infections, specifically in oncology patients in United States, is identified as a concern, and the authors advocate for a centralized and specialized surveillance system for patients with cancer to predict and prevent the emergence of antibiotic resistance. Finding better ways to predict, prevent, and treat antibiotic-resistant infections will have a major positive impact on the care of those with cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI